phenethylamine

monoamine oxidase B ; Homo sapiens







29 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33081086 Performance of Force-Field- and Machine Learning-Based Scoring Functions in Ranking MAO-B Protein-Inhibitor Complexes in Relevance to Developing Parkinson's Therapeutics. 2020 Oct 16 2
2 33103897 Click-Reaction-Triggered SERS Signals for Specific Detection of Monoamine Oxidase B Activity. 2020 Nov 17 6
3 31303592 Ligand based screening of chemical constituents from African medicinal plants for the identification of MAOB inhibitors. 2019 May 2
4 31556440 Neurotransmitter selection by monoamine oxidase isoforms, dissected in terms of functional groups by mixed double mutant cycles. 2019 Oct 21 2
5 29202379 Platelet monoamine oxidase activity and interpersonal violence in male suicide attempters. 2018 Feb 1
6 25253656 Profiling substrate specificity of two series of phenethylamine analogs at monoamine oxidase A and B. 2014 Nov 21 1
7 20073575 Characterization of monoamine oxidases in mesenchymal stem cells: role in hydrogen peroxide generation and serotonin-dependent apoptosis. 2010 Oct 1
8 20832472 On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B. 2010 Dec 2
9 14697876 Progress in monoamine oxidase (MAO) research in relation to genetic engineering. 2004 Jan 1
10 15569272 Enzymatic oxidation of 2-phenylethylamine to phenylacetic acid and 2-phenylethanol with special reference to the metabolism of its intermediate phenylacetaldehyde. 2004 Dec 1
11 20641293 7-[ 11C]Methoxy-1-methyl-9H-[3,4-b]indole 2004 1
12 20641420 [11C](5R)-5-(Methoxymethyl)-3-[4-[(3R)-4,4,4-trifluoro-3-hydroxybutoxy]phenyl]-2-oxazolidinone 2004 1
13 20642018 (S)-5-Methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[d]isoxazol-3-yl]-oxazolidin-2-[11C]one 2004 1
14 14628189 A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition. 2003 Nov 3
15 11134050 Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid. 2001 Mar 30 2
16 11160474 Platelet monoamine oxidase B and plasma beta-phenylethylamine in Parkinson's disease. 2001 Feb 4
17 11797065 Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors. 2001 Dec 4
18 10936214 Phe(208) and Ile(199) in human monoamine oxidase A and B do not determine substrate and inhibitor specificities as in rat. 2000 Sep 1
19 9503561 [Discovery of monoamine oxidase forms A and B]. 1997 Nov-Dec 1
20 8847600 SAR studies of fluorine-substituted benzylamines and substituted 2-phenylethylamines as substrates and inactivators of monoamine oxidase B. 1995 1
21 7721026 Pharmacological and clinical implications of MAO-B inhibitors. 1994 Dec 1
22 1609114 The new generation of monoamine oxidase inhibitors. 1992 1
23 1759390 [The role of monoamine oxidase in the regulation of mitochondrial energy functions]. 1991 Sep-Oct 1
24 3116977 [Blood phenolsulfotransferase and monoamine oxidase-B activity in essential arterial hypertension]. 1987 Jun 1
25 3118881 [13N]-beta-phenethylamine ([13N]PEA): a prototype tracer for measurement of MAO-B activity in heart. 1987 Nov 1 1
26 3833630 Measurement of platelet monoamine oxidase using three different substrates in patients with alcoholism and schizophrenia. 1985 1
27 3928010 Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat. 1985 Jun 2
28 7422056 Titration of human brain type-B monoamine oxidase. 1980 Jul 1
29 745019 Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration. 1978 1